CRY1 and neoplasm: Paradoxically, we found that patients with a higher expression of CRY1 in their tumours showed lower OS and DFS, probably because these patients also showed an increased risk of developing MM at 3 and 5 years after diagnosis of the disease, which could be used as an advantage for the management of these patients.